FGEN: Nilai perusahaan marang bathi resik FibroGen Corp
High patent barriers and stringent FDA oversight protect the business of FibroGen, Inc. (FGEN), which is collaborating with AstraZeneca and Astellas to launch cancer and anemia treatments on the global market. This price chart reflects a P/E ratio of 0.20. The company is currently battling a liquidity shortage, reducing headcount and optimizing expenses following the failure of several tests.
%20Rasio%20rega%20marang%20bathi&width=1200&height=400&colorIndex=0&v=mwa76aez.ocr-7cpmfb4&start=20220704&end=20261110&filename=GURU_Markets_-_FGEN_-_FibroGen-Inc._-_Price-to-Earnings-Ratio "fibrogen.com (FGEN): Kapitalisasi marang bathi saka 04.07.2022 nganti 08.01.2026 | 👁️GURU.Markets👁️")
Rincian metrik komprehensif lan analitis FibroGen Corp (FGEN)
- rega lan prakiraan konsensus rega:
- informasi kapitalisasi pasar:
- indikator nilai aset resik miturut neraca:
- data liabilitas lan likuiditas perusahaan:
Rasio Kabeh Utang marang Dana Pribadi FibroGen, Inc.|FGEN - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal FibroGen Corporation|FGEN - Utang perusahaan|Rasio utang marang aset resik FibroGen, Inc.|FGEN - Utang jangka dawa perusahaan|Kewajiban jangka cendhak FibroGen|Koefisien jangkoan perantara fibrogen.com
- data bathi bisnis lan rasio investasi:
FGEN - Bathi resik|Bathi sing dikarepake FibroGen, Inc.|FGEN - Rasio rega marang bathi|Pangali mangsa ngarep rega marang bathi FibroGen Inc|FGEN - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan FibroGen, Inc.|FGEN - Bathi operasional EBITDA|Bathi resik saben saham sajroning taun lumaku FibroGen|FGEN - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan fibrogen.com|FGEN - Wutah bathi saben saham ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep FibroGen, Inc.
Analisis komprehensif perusahaan:fibrogen.com - FGEN
For FibroGen, Inc. (FGEN), the P/E ratio serves as an indicator of market confidence amid waning revenues from core licensing assets. By analyzing the price-to-earnings trend, an investor assesses the ratio of market capitalization to net income, which allows for the timely identification of overvaluation and protects capital from risks associated with slowing cash flows within the pharmaceutical business.
Pesaing wigati
Pangali P/E haleon.com|Koefisien rega marang bathi KVUE (Kenvue)|VRNA (Verona Pharma PLC) - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Jyong Biotech Corp MENS|Ligand Corp (LGND) - Kapitalisasi marang bathi|AMRX: Koefisien rega marang bathi|perrigo.com - Rasio rega pasar marang bathi resik|ALVO: Pangali P/E|Liquidia Corp - Nilai perusahaan marang bathi resik|GLPG (Galapagos Genomics) - Pangali P/E|Kapitalisasi marang bathi ANI Pharmaceuticals Corp ANIP|Rasio rega marang bathi MannKind Corporation (MNKD)|AMPH (amphastar.com) - Nilai perusahaan marang bathi resik|Pangali P/E PCRX (Pacira BioSciences, Inc.)|SPRY (ARS Pharmaceuticals Inc) - Kapitalisasi marang bathi resik|Theravance - Pangali P/E|Periode bali modal bisnis Aquestive Corp AQST|SCPH: Pangali P/E|TECX (Tectonic Therapeutic) - Rasio rega marang bathi|Rasio rega marang bathi Tonix Pharmaceuticals Holding Corp.|SXTC: Nilai perusahaan marang bathi resik|Rasio rega marang bathi Eupraxia Pharmaceuticals (EPRX)|BHST - Kapitalisasi marang bathi|Pangali P/E EXOZ (eXoZymes Inc)|Rasio kapitalisasi marang bathi resik Oramed|Entera Bio Corp - Pangali P/E|Kapitalisasi marang bathi MindWalk Holdings, Inc.|ABVC BioPharma Inc (ABVC) - Rasio rega marang bathi|Pangali rega marang bathi CPIX|Koefisien rega marang bathi QNTM|TELO: Nilai perusahaan marang bathi resik|Pangali P/E RANI|Periode bali modal bisnis synergychc.com|Rasio rega marang bathi Rallybio RLYB|LEXX: Pangali rega marang bathi|Pulmatrix, Inc. - Pangali P/E|Pheton Holdings Ltd (PTHL) - Koefisien rega marang bathi|APM (aptorumgroup.com) - Koefisien rega marang bathi|LYRA - Periode bali modal bisnis|IBO (Impact BioMedical) - Pangali P/E|TNF Pharma - Kapitalisasi marang bathi resik|Pangali P/E YCBD|painreform.com (PRFX) - Rasio kapitalisasi marang bathi resik|Pangali P/E CYTO (Altamira Therapeutics Ltd.)|Lipella Pharmaceuticals Inc (LIPO) - Kapitalisasi marang bathi|OPTN - Rasio rega marang bathi|PIRS (Pieris Pharma) - Pangali rega marang bathi|Procaps Group S.A. (PROC) - Rasio rega marang bathi|Kapitalisasi marang bathi resik PTPI (petrospharma.com)|QLI (Qilian International Holding) - Pangali P/E|SLRN: Nilai perusahaan marang bathi resik|Pangali P/E TFFP
